Vaxxinity, Inc. Annual Operating Income (Loss) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Vaxxinity, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
  • Vaxxinity, Inc. Operating Income (Loss) for the quarter ending December 31, 2023 was -$11.6M, a 44.3% increase year-over-year.
  • Vaxxinity, Inc. Operating Income (Loss) for the twelve months ending December 31, 2023 was -$58.3M, a 23.3% increase year-over-year.
  • Vaxxinity, Inc. annual Operating Income (Loss) for 2023 was -$58.3M, a 23.3% increase from 2022.
  • Vaxxinity, Inc. annual Operating Income (Loss) for 2022 was -$76M, a 39.3% increase from 2021.
  • Vaxxinity, Inc. annual Operating Income (Loss) for 2021 was -$125M, a 287% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$58.3M +$17.7M +23.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 -$76M +$49.1M +39.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 -$125M -$92.8M -287% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2020 -$32.3M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.